Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.
作者信息
Cheung Angela M, Feig Denice S, Kapral Moira, Diaz-Granados Natalia, Dodin Sylvie
机构信息
Women's Health Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
出版信息
CMAJ. 2004 May 25;170(11):1665-7. doi: 10.1503/cmaj.1030757.
Abstract
摘要
相似文献
1
Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.
CMAJ. 2004 May 25;170(11):1665-7. doi: 10.1503/cmaj.1030757.
2
Evaluation and treatment of postmenopausal osteoporosis.
Am J Manag Care. 2001 Sep 25;7 Spec No:SP5-16.
3
Maintaining skeletal health among postmenopausal women.
Am J Manag Care. 1998 Mar;4(3):387-96.
4
Treatment considerations in the management of age-related osteoporosis.
Am J Med Sci. 1999 Sep;318(3):158-70.
5
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians.
Ann Intern Med. 2017 Jun 6;166(11):818-839. doi: 10.7326/M15-1361. Epub 2017 May 9.
6
ERT, HRT, raloxifine, calcitonin, or bisphosphonates for osteoporosis.
J Manag Care Pharm. 2003 Mar-Apr;9(2):178-81. doi: 10.18553/jmcp.2003.9.2.178.
7
Raloxifene: a new choice for treating and preventing osteoporosis.
Cleve Clin J Med. 2000 Apr;67(4):273-80. doi: 10.3949/ccjm.67.4.273.
8
The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis.
Rheum Dis Clin North Am. 2001 Feb;27(1):163-85, vii. doi: 10.1016/s0889-857x(05)70192-7.
9
Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
J Reprod Med. 2003 Jun;48(6):425-34.
10
Prevention of corticosteroid-induced osteoporosis and fractures.
J Clin Pharm Ther. 1999 Apr;24(2):83-5. doi: 10.1046/j.1365-2710.1999.00209.x.
引用本文的文献
1
Screening for osteoporosis: A systematic assessment of the quality and content of clinical practice guidelines, using the AGREE II instrument and the IOM Standards for Trustworthy Guidelines.
PLoS One. 2018 Dec 6;13(12):e0208251. doi: 10.1371/journal.pone.0208251. eCollection 2018.
2
Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada.
Osteoporos Int. 2017 Dec;28(12):3439-3449. doi: 10.1007/s00198-017-4218-6. Epub 2017 Oct 9.
3
The Tissue-Selective Estrogen Complex: A Review of Current Evidence.
Rheumatol Ther. 2015 Jun;2(1):47-58. doi: 10.1007/s40744-015-0013-z. Epub 2015 May 20.
4
Effects of Polygonatum sibiricum polysaccharide on the osteogenic differentiation of bone mesenchymal stem cells in mice.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6169-80. eCollection 2015.
5
Copper, magnesium, zinc and calcium status in osteopenic and osteoporotic post-menopausal women.
Clin Cases Miner Bone Metab. 2015 Jan-Apr;12(1):18-21. doi: 10.11138/ccmbm/2015.12.1.018.
6
Euodia sutchuenensis Dode extract stimulates osteoblast differentiation via Wnt/β-catenin pathway activation.
Exp Mol Med. 2015 Mar 20;47(3):e152. doi: 10.1038/emm.2014.115.
7
Bone density in haemophilia: a single institutional cross-sectional study.
Haemophilia. 2014 Jan;20(1):121-8. doi: 10.1111/hae.12240. Epub 2013 Aug 1.
8
The complex interplay of depression and falls in older adults: a clinical review.
Am J Geriatr Psychiatry. 2013 May;21(5):484-92. doi: 10.1016/j.jagp.2013.01.008. Epub 2013 Feb 6.
9
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
10
An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures.
J Bone Miner Res. 2013 Feb;28(2):383-94. doi: 10.1002/jbmr.1758.
本文引用的文献
1
Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care.
CMAJ. 2004 May 11;170(10):1535-7. doi: 10.1503/cmaj.1030756.
2
The 2002 Canadian bone densitometry recommendations: take-home messages.
CMAJ. 2002 Nov 12;167(10):1141-5.
3
Screening for osteoporosis in postmenopausal women: recommendations and rationale.
Ann Intern Med. 2002 Sep 17;137(6):526-8. doi: 10.7326/0003-4819-137-6-200209170-00014.
4
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).
Osteoporos Int. 2000;11(10):897-904. doi: 10.1007/s001980070050.
5
Perspective. How many women have osteoporosis?
J Bone Miner Res. 1992 Sep;7(9):1005-10. doi: 10.1002/jbmr.5650070902.
Zotero 插件